This protocol covers the first-line management of mild cytomegalovirus (CMV) colitis — a presentation in which an oral antiviral regimen is appropriate and clinical recovery is achievable within a defined treatment window.
Mild cytomegalovirus colitis. Disease severity in this sub-population supports management with oral therapy rather than intravenous alternatives.
An oral antiviral agent is the basis of treatment in this setting. The full regimen — including dosing schedule and treatment duration — is laid out in the structured protocol.
Treatment success is defined as resolution of signs and symptoms of CMV colitis, assessed over the course of the treatment period.